Clinical trial
Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels
NCT00188539 · University Health Network, Toronto, Other · Active, not recruiting
Key facts
| NCT number | NCT00188539 |
|---|---|
| Title | Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels |
| Official title | Predictive Assays in Cervix Cancer: Assessment of Hypoxia, Interstitial Fluid Pressure, and GSH Levels |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Canadian Cancer Trials Group Princess Margaret Hospital, Canada |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervix Neoplasms |
| Intervention type | Procedure |
| Interventions | Pre-treatment tumour oxygen measurements (under anesthesia) |
| Enrollment | 300 |
| Start date | Dec 1, 1995 |
| Primary completion | Dec 1, 2027 |
| Completion | Dec 1, 2027 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 20, 2025 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: